Robertta Silva Martins

Robertta Silva Martins

Auto-generated profile, based on publicly available information

Robertta Silva Martins

Laboratório de Neurofarmacologia, Instituto Biomédico Universidade Federal Fluminense Niterói Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
Adam Armada-MoreiraAdam Armada-Moreira
Adam Armada-Moreira
JGJoana I. Gomes
Joana I. Gomes
CPCarolina Campos Pina
Carolina Campos Pina
OSOksana K. Savchak
Oksana K. Savchak
JGJoana Gonçalves-Ribeiro
Joana Gonçalves-Ribeiro
SVSandra H. Vaz
Sandra H. Vaz
Excitotoxicity is a phenomenon that describes the toxic actions of excitatory neurotransmitters, primarily glutamate, where the exacerbated or prolonged activation of glutamate receptors starts a cascade of neurotoxicity that ultimately leads to the loss of neuronal function and cell death. In this process, the shift between normal physiological function and excitotoxicity is largely controlled by astrocytes since they can control the levels of glutamate on the synaptic cleft. This control is achieved through glutamate clearance from the synaptic cleft and its underlying recycling through the glutamate-glutamine cycle. The molecular mechanism that triggers excitotoxicity involves alterations in glutamate and calcium metabolism, dysfunction of glutamate transporters, and malfunction of glutamate receptors, particularly N-methyl-D-aspartic acid receptors (NMDAR). On the other hand, excitotoxicity can be regarded as a consequence of other cellular phenomena, such as mitochondrial dysfunction, physical neuronal damage, and oxidative stress. Regardless, it is known that the excessive activation of NMDAR results in the sustained influx of calcium into neurons and leads to several deleterious consequences, including mitochondrial dysfunction, reactive oxygen species (ROS) overproduction, impairment of calcium buffering, the release of pro-apoptotic factors, among others, that inevitably contribute to neuronal loss. A large body of evidence implicates NMDAR-mediated excitotoxicity as a central mechanism in the pathogenesis of many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), and epilepsy. In this review article, we explore different causes and consequences of excitotoxicity, discuss the involvement of NMDAR-mediated excitotoxicity and its downstream effects on several neurodegenerative disorders, and identify possible strategies to study new aspects of these diseases that may lead to the discovery of new therapeutic approaches. With the understanding that excitotoxicity is a common denominator in neurodegenerative diseases and other disorders, a new perspective on therapy can be considered, where the targets are not specific symptoms, but the underlying cellular phenomena of the disease.

Verified
Journal Article
Open access
PDF file
FGFernanda Gubert
Fernanda Gubert
JSJaqueline Da Silva
Jaqueline Da Silva
JVJuliana Vasques
Juliana Vasques
RGRenata Guedes de Jesus Gonçalves
Renata Guedes de Jesus Gonçalves
RMRobertta Silva Martins
Robertta Silva Martins
GZGisele Zapata-Sudo
Gisele Zapata-Sudo
Stem cell therapy is a promising alternative approach to heart diseases. The most prevalent source of multipotent stem cells, usually called somatic or adult stem cells (mesenchymal stromal/stem cells, MSCs) used in clinical trials is bone marrow (BM-MSCs), adipose tissue (AT-MSCs), umbilical cord (UC-MSCs) and placenta. Therapeutic use of MSCs in cardiovascular diseases is based on the benefits in reducing cardiac fibrosis and inflammation that compose the cardiac remodeling responsible for the maintenance of normal function, something which may end up causing progressive and irreversible dysfunction. Many factors lead to cardiac fibrosis and failure, and an effective therapy is lacking to reverse or attenuate this condition. Different approaches have been shown to be promising in surpassing the poor survival of transplanted cells in cardiac tissue to provide cardioprotection and prevent cardiac remodeling. This review includes the description of pre-clinical and clinical investigation of the therapeutic potential of MSCs in improving ventricular dysfunction consequent to diverse cardiac diseases.

6 October 2020 in Purinergic Signalling
Verified
Journal Article
Closed access
PDF file
RMRobertta S. Martins
Robertta S. Martins
DRDiogo M. Rombo
Diogo M. Rombo
JGJoana Gonçalves-Ribeiro
Joana Gonçalves-Ribeiro
CMCarlos Meneses
Carlos Meneses
VBVladimir P. P. Borges-Martins
Vladimir P. P. Borges-Martins
ASAna M. Sebastião
Ana M. Sebastião

1 January 2018 in Neurochemistry International
Verified
Journal Article
Closed access
RKRegina Célia Cussa Kubrusly
Regina Célia Cussa Kubrusly
AGAlexander Günter
Alexander Günter
LSLuzia da Silva Sampaio
Luzia da Silva Sampaio
RMRoberta Silva Martins
Roberta Silva Martins
CSClarissa S. Schitine
Clarissa S. Schitine
Ricardo Augusto de Melo ReisRicardo Augusto de Melo Reis
Ricardo Augusto de Melo Reis

1 November 2016 in Neuroscience
Verified
Journal Article
Closed access
AFAdriana Pinto de Freitas
Adriana Pinto de Freitas
DFDanielle Dias Pinto Ferreira
Danielle Dias Pinto Ferreira
AFArlete Fernandes
Arlete Fernandes
RMRobertta Silva Martins
Robertta Silva Martins
VBVladimir Pedro Peralva Borges-Martins
Vladimir Pedro Peralva Borges-Martins
RKRegina Célia Cussa Kubrusly
Regina Célia Cussa Kubrusly

1 August 2016 in Neuroscience
Verified
Journal Article
Closed access
MSMatheus Figueiredo Sathler
Matheus Figueiredo Sathler
BSBernardo Stutz
Bernardo Stutz
RMRobertta Silva Martins
Robertta Silva Martins
MPMaurício dos Santos Pereira
Maurício dos Santos Pereira
NPNey Roner Pecinalli
Ney Roner Pecinalli
RKRegina Célia Cussa Kubrusly
Regina Célia Cussa Kubrusly